Changes of plasma activated Factor XII type a (XIIaA) concentrations following percutaneous coronary intervention (PCI)

Journal of Thrombosis and Thrombolysis

Volumn 24, Issue 2, 2007, Pages 131-135

  Pönitz, Volker ^a,b   Pritchard, David ^c   Grundt, Heidi ^a,b   Mehus, Mai Britt ^a   Nilsen, Dennis Winston T ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Axis Shield Diagnostics Ltd   (United Kingdom)

Author keywords

Factor XIIa; Myocardial infarction; Non ionic contrast media; Percutaneous coronary intervention; Unfractionated heparin

Indexed keywords

BLOOD CLOTTING FACTOR 12; CONTRAST MEDIUM; HEPARIN;

ANGIOCARDIOGRAPHY; ARTICLE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HUMAN; TRANSLUMINAL CORONARY ANGIOPLASTY; UPREGULATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XII; HEPARIN; HUMANS; MYOCARDIAL INFARCTION; UP-REGULATION;

EID: 34447299267     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-007-0041-9     Document Type: Article

References (15)

1. Zito F, Drummond F, Bujac SR et al (2000) Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men. Circulation 102:2058-2062
2. Kohler HP, Carter AM, Stickland MH et al (1998) Levels of activated FXII in survivors of myocardial infarction: association with circulating risk factors and extent of coronary artery disease. Thromb Haemost 79:14-18 (Pubitemid 28037048)
3. Grundt H, Nilsen DW, Hetland O et al (2004) Activated factor 12 (XIIa) predicts recurrent coronary events after an acute myocardial infarction. Am Heart J 147:260-266 (Pubitemid 38176826)
4. Pritchard D, Polwart R (2005) In-vivo, activated factor XII exists in multiple forms, but predominantly as a 53 kD Species. J Thromb and Haemost Suppl.1; ISSN 1740-3340
5. Pönitz V, Pritchard D, Grundt H, Nilsen DW (2006) Specific types of activated Factor XII increase following thrombolytic therapy with tenecteplase. J Thromb Thrombolysis 22:199-203 (Pubitemid 44857781)
6. Grines CL, Cox DA, Stone GW et al (1999) Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 341:1949-1956 (Pubitemid 30010402)
7. Altieri P, Devoto E, Spallarossa P et al (2005) Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity. Thromb Res 115:65-72 (Pubitemid 39572757)
8. Esnouf MP, Burgess AI, Dodds AW et al (2000) A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor. Thromb Haemost 83:874-881 (Pubitemid 30411686)
9. Renne T, Pozgajova M, Gruner S et al (2005) Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 202:271-281 (Pubitemid 41043823)
10. Laurie AJ, Lyon SG, Lasser EC (1991) The effects of contrast media on coagulation factor XII. Invest Radiol 26:23-25
11. Pixley RA, Casselo A, De La Caneda RA, et al (1991) Effect of Heparin on the activation of Factor XII and the contact system in plasma. Thromb Haemost 66:540-547
12. Fuhrer G, Gallimore MJ, Heller W et al (1990) FXII. Blut 61:258-266
13. Hojima Y, Cochrane CG, Wiggins RC et al (1984) In vitro activation of the contact (Hageman Factor) system of the plasma by heparin and chondroitin sulphate E. Blood 63:1453-1459 (Pubitemid 14120394)
14. Coppola R, Cristilli M, Cugno R et al (1996) Measurement of activated factor XII in health and disease. Blood Coagul Fibrinolysis 7:530-535 (Pubitemid 26294882)
15. Sanchez J, Elgue G, Riesenfeld J et al (1998) Studies of adsorption, activation, and inhibition of Factor XII on immobilized heparin. Thromb Res 89:41-50 (Pubitemid 28231485)